GVHD
GVHD
Patrick DalyGVHD | November 23, 2022
Patients reported significant symptom burden and daily activity impairments in the online Living With Chronic GVHD Patient Su
Read More
Patrick DalyGVHD | November 23, 2022
Researchers found bronchiolitis obliterans syndrome was less frequent in HCT with HID donors compared with MSD and MUDs.
Patrick DalyGVHD | November 23, 2022
Researchers found sVCAM-1 levels were higher pre- and post-HCT in patients who developed severe aGVHD.
Patrick DalyGVHD | November 23, 2022
Extracellular vesicles at engraftment in hematopoietic cell transplantation may be a feasible biomarker for acute GVHD.
Patrick DalyGVHD | November 16, 2022
Patients with steroid-refractory acute graft-versus-host disease who received ECP had better survival than those who did not.
Patrick DalyGVHD | November 16, 2022
Investigators found greater risk for severe acute graft-versus-host disease in omitting the day 11 dose of mini-methotrexate.
Patrick DalyGVHD | November 16, 2022
Mocravimod, a S1PR modulator, showed manageable safety and promising efficacy in GVHD.
Patrick DalyGVHD | November 16, 2022
Leukapheresis was able to collect and store cells from patients with graft-versus-host disease for use in future trials.
Patrick DalyGVHD | November 8, 2022
Vitamin D receptor deficiency appeared to play a major role in the pathology of gastrointestinal graft-versus-host disease.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | November 8, 2022
Elaine DeMeyer, nursing veteran, describes a live case study on the potential trauma in patients with GVHD.
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®GVHD | November 8, 2022
Oncology Nurse, Elaine DeMeyer, describes how to distinguish liver iron overload and liver graft-versus-host disease.
Patrick DalyGVHD | November 8, 2022
Reduced bone marrow mesenchymal stromal cells predicted the development of acute graft-versus-host disease.
Patrick DalyGVHD | October 24, 2022
Different doses of ATLG prior to HCT had a significant impact on immune reconstitution, but not GVHD outcomes.
Patrick DalyGVHD | October 24, 2022
Researchers described disease and treatment trends in patients with aGVHD and highlighted the population's unmet needs.
Patrick DalyGVHD | October 24, 2022
Researchers developed a diagnostic classifier that improved chronic graft-versus-host disease diagnosis in children.
Patrick DalyGVHD | October 24, 2022
PTCy-based GVHD prophylaxis showed superior GRFS and OS compared with ATG-based prophylaxis in a recent study.
Patrick DalyGVHD | October 14, 2022
Researchers reported that PTCy regimens led to a “low, but not negligible," incidence of chronic GVHD after haplo-HSCT.
Patrick DalyGVHD | October 14, 2022
Combined reduced-dose ATG and PTCy improved GVHD outcomes compared with a standard ATG regimen.
Patrick DalyGVHD | October 14, 2022
ICCGVHD score had good sensitivity, specificity, predictive value, and correlation with the 2014 NIH ocular GVHD criteria.
Patrick DalyGVHD | October 14, 2022
Orca-T, an investigational allograft, reduced chronic GVHD, improved GRFS, and had manageable toxicity, according to study.
Advertisement
Advertisement